Biotechnology R&D and strategy leader, expert in bridging the gap between what is feasible (R&D) and what is strategic (marketing) in cell biology-related markets. I have led and advised teams delivering new-technology products to multiple market segments, including cell therapy enablement tools, cell analysis instruments and reagents, cell culture environments for stem cell manufacturing and research, clinical specimen technologies, and bioinformatics tools. I have been fortunate to play a significant role in reducing the 'art' of cell biology to practice in order to create lucrative new business opportunities addressing critical market needs.Specialties: Technology and product development, strategic alliances, R&D leadership, cell biology, signal transduction biology, stem cell therapeutics and regenerative medicine, high content screening technology, cell analysis, assay development, flow cytometry, mammalian cell culture technologies, research automation, bioinformatics.
Listed skills include Technology Program Turn Arounds, Due Diligence, Strategic Marketing, M&A Advising, and 21 others.